Elucidating the Benefit of Radiation Therapy in GI Cancers: Rethinking Trial End Points and Patient Selection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elucidating the Benefit of Radiation Therapy in GI Cancers: Rethinking Trial End Points and Patient Selection

Published:2023-10-19 Issue: Volume: Page:
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Sanford Nina N.¹^ORCID,Hong Theodore S.²^ORCID,Hall William A.³^ORCID

Affiliation:

1. Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX

2. Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

3. Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.01402

Reference31 articles.

1. Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer Type

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upping the Ante in the Treatment of Gastrointestinal Cancer;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. Accrual to Radiotherapy Trials in the US—Pitfalls and Potential Solutions;JAMA Oncology;2024-09-12

3. Critical Appraisal and Future Challenges of Artificial Intelligence and Anticancer Drug Development;Pharmaceuticals;2024-06-21

4. Are We Losing the Final Fight against Cancer?;Cancers;2024-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP